Facilitated By

San Antonio Medical Foundation

News

  • Viking oral obesity med posts 6.8% weight loss for highest dose - Fierce Biotech

    The biotech had tested the oral asset, dubbed VK2735, at doses ... In a Sunday poster presentation at the ObesityWeek conference in San Antonio ...

  • Kazia Therapeutics Announces Granting of Type C Meeting with FDA to Discuss Potential ...

    San Antonio Breast Cancer Symposium, December 10-13, 2024, in San ... Biotechnology: Pharmaceutical Preparations. Health Care. Electric ...

  • Scorpius Holdings Announces Collaboration with Celltheon Corporation, a U.S.-Based Cell ...

    The collaboration enables clients to work with Scorpius' program management team while preparing to transfer research cell banks to their San Antonio ...

  • BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast ...

    BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium®, December 10 – 13 · In This Article:.

  • bioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development

    SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW) (“bioAffinity” or the “Company”), a biotechnology company ...